Cencora, Inc.

COR

Explore Our Financial Data > Companies > Cencora, Inc.

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	COR
CIK	0001140859
SIC	5122
Sector	Wholesale Trade
Industry Category	Wholesale
Industry Group	Wholesale – Drugs & Drug Proprietaries

Contact

Address	1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
Website	www.cencora.com
Phone	610-727-7000
CEO	Steven H. Collis
Employees	42,000

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$321.33 billion
Pre-Tax Income	$2.26 billion
Net Income	$1.57 billion
Net Income to Common	$1.55 billion
EPS	$7.96

View All

Balance Sheet

Cash	$4.36 billion
Assets	$76.59 billion
Liabilities	$74.84 billion
Common Equity	$1.51 billion
Liabilities & Equity	$76.59 billion

View All

Cash Flow Statement

Net Income	$1.57 billion
Cash From Operating Activities	$3.88 billion
Cash From Investing Activities	$-4.98 billion
Cash From Financing Activities	$2.25 billion
Change in Cash	$1.10 billion

View All

Calculations

NOPAT	$1.82 billion
EBITDA	$3.62 billion
Price to Earnings	$43.19
Price to Book	$44.51
ROE	123.75%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Cencora’s Expanded Cold Chain and 3PL Network Might Change The Case For Investing In Cencora (COR)

Cencora recently announced it has expanded its global third-party logistics capabilities by acquiring NextPharma Logistics in Germany, Austria and Switzerland, investing in additional cold chain capacity across Europe, and committing to a new highly automated 500,000 square-foot 3PL facility in Texas expected to be operational in 2028. This build-out of temperature-controlled and cryogenic infrastructure deepens Cencora’s role in handling complex specialty medicines, positioning its...

Article Link

Cencora (COR) Valuation Check as Logistics Expansion and Earnings Upgrades Fuel Investor Interest

Cencora (COR) is back on investors radar after unveiling major upgrades to its third party and specialty logistics network in the United States and Europe, moves that neatly reinforce its improving earnings outlook. See our latest analysis for Cencora. The latest logistics expansion comes on the back of strong momentum, with a year to date share price return of 53.29% and a five year total shareholder return of 268.75%, suggesting investors are steadily repricing Cencora’s growth and...

Article Link

Here's Why You Should Add Cencora Stock to Your Portfolio Now

Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.

Article Link

Is Cardinal Health Stock Outperforming the Nasdaq?

Cardinal Health has outperformed the broader Nasdaq index over the past year. Moreover, Wall Street analysts remain strongly optimistic about its prospects.

Article Link

Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?

Here is how Cencora (COR) and CorMedix (CRMD) have performed compared to their sector so far this year.

Article Link